Leadership Overview
Zydus has 10 executives leading key functions including strategy, finance, technology, operations, and human resources.
Driven by innovation, Zydus is a global pharmaceutical company dedicated to developing, manufacturing, and distributing essential medicines worldwide, impacting healthcare across regulated and emerging markets.
Driven by innovation, Zydus is a global pharmaceutical company dedicated to developing, manufacturing, and distributing essential medicines worldwide, impacting healthcare across regulated and emerging markets.
Leadership Roles at Zydus
Hilal Wani - Chief Executive Officer
Hilal Wani, the Chief Executive Officer at Zydus, directs the company's overarching strategy and global operations. Wani oversees the development and execution of Zydus's business plans, ensuring alignment with market demands and corporate objectives. This leadership role involves guiding all functional departments to achieve Zydus's mission of delivering high-quality pharmaceutical products. By fostering innovation and operational excellence, Hilal Wani drives the company's expansion into new therapeutic areas and geographic markets, solidifying Zydus's position as a significant player in the global pharmaceutical landscape. The Chief Executive Officer's focus remains on sustainable growth and enhancing patient access to critical medicines.
Tushar Shroff - Chief Financial Officer
Tushar Shroff, the Chief Financial Officer at Zydus, manages all financial aspects of the global pharmaceutical operations. Shroff directs financial planning, budgeting, and reporting, ensuring fiscal responsibility across the organization. This critical role involves optimizing capital allocation and managing investment strategies to support Zydus's growth initiatives in India, the United States, and Brazil. By maintaining robust financial controls and driving efficiency, Tushar Shroff ensures the company's long-term economic health and its ability to fund research and development. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding Zydus's assets and stakeholder value.
Vikram Shukla - President
Vikram Shukla, the President at Zydus, drives strategic initiatives and operational execution across key business segments. Shukla oversees the implementation of Zydus's global expansion plans, focusing on strengthening market presence in regulated and emerging markets. This executive role involves fostering cross-functional collaboration to accelerate product development and market access. By championing operational excellence, Vikram Shukla ensures that Zydus consistently delivers high-quality pharmaceutical products and services. The President's leadership contributes significantly to the company's overall growth trajectory and its commitment to improving patient outcomes worldwide.
Kacharu Toshniwal - President
Kacharu Toshniwal, the President at Zydus, leads critical operational functions and strategic development within the organization. Toshniwal directs efforts to enhance manufacturing capabilities and optimize supply chain logistics across Zydus's global network, including sites in India, the United States, and Brazil. This executive position focuses on ensuring the efficient and compliant production of pharmaceutical products. By driving process improvements and technological integration, Kacharu Toshniwal supports Zydus's commitment to delivering affordable and accessible medicines. The President's oversight is vital for maintaining the integrity and scalability of Zydus's manufacturing operations.
Dr.Amrut Naik - President
Dr.Amrut Naik, the President at Zydus, guides the company's extensive research and development endeavors. Naik oversees the discovery and clinical development of novel pharmaceutical products, driving innovation in therapeutic areas critical to global health. This leadership role involves managing scientific teams and ensuring the rigorous progression of drug candidates through regulatory pathways. By fostering a culture of scientific excellence, Dr.Amrut Naik advances Zydus's mission to address unmet medical needs. The President's strategic direction is fundamental to expanding Zydus's portfolio of innovative treatments and enhancing patient care worldwide.
Mangesh Vaze - President, Api Business
Mangesh Vaze, the President, Api Business at Zydus, directs the strategic growth and operational management of the Active Pharmaceutical Ingredients (API) division. Vaze oversees the development, manufacturing, and global distribution of high-quality APIs, serving both internal Zydus needs and external pharmaceutical clients. This executive role is crucial for maintaining Zydus's integrated supply chain and ensuring the consistent availability of essential drug components. By focusing on technological innovation and stringent quality control, Mangesh Vaze strengthens Zydus's position as a reliable supplier in the global API market. The President, Api Business's leadership ensures compliance with international regulatory standards.
Rashmin Shah - President
Rashmin Shah, the President at Zydus, drives the company's commercial strategies and market penetration efforts. Shah oversees the sales and marketing functions, ensuring effective product launches and sustained market presence across Zydus's key geographies, including the United States, Europe, and Latin America. This executive position focuses on expanding Zydus's reach and maximizing revenue generation. By cultivating strong relationships with healthcare providers and distributors, Rashmin Shah enhances Zydus's brand visibility and market share. The President's strategic guidance is instrumental in achieving Zydus's commercial objectives and improving patient access to its pharmaceutical offerings.
Rishikesh Raval - Group President, Human Resources & Corporate Communications
Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, leads the strategic development and implementation of human capital management and external relations. Raval oversees all aspects of talent acquisition, employee development, and organizational culture, ensuring Zydus attracts and retains top talent globally. This critical role also directs corporate communications, shaping Zydus's public image and stakeholder engagement across India and international markets. By fostering a supportive and dynamic work environment, Rishikesh Raval contributes to Zydus's operational success and its reputation as a responsible corporate citizen. The Group President's focus is on aligning human resources with Zydus's long-term strategic goals.
Harish Sadana - President Corporate Matters
Harish Sadana, the President Corporate Matters at Zydus, manages essential corporate functions and strategic initiatives that underpin the company's operations. Sadana oversees critical administrative and legal frameworks, ensuring Zydus adheres to all regulatory requirements across its global footprint. This executive role involves coordinating complex projects and ensuring seamless integration of corporate policies. By providing strategic oversight on corporate affairs, Harish Sadana supports Zydus's commitment to ethical business practices and operational integrity. The President Corporate Matters's leadership ensures that Zydus maintains a strong foundation for sustainable growth and compliance.
Arun Behal - Chief Technical Officer & Chief Technology Officer
Arun Behal, the Chief Technical Officer & Chief Technology Officer at Zydus, spearheads the company's technological advancements and technical operations. Behal directs the integration of cutting-edge technologies across manufacturing, research, and distribution, enhancing efficiency and product quality. This leadership position involves overseeing the technical infrastructure that supports Zydus's extensive research and development capabilities. By driving innovation in process technology and digital transformation, Arun Behal ensures Zydus maintains a competitive edge in the pharmaceutical industry. The Chief Technical Officer & Chief Technology Officer's responsibilities include managing technical teams and ensuring compliance with global regulatory standards for all Zydus products.
Explore Leadership Teams in Manufacturing
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
AC
Bliss GVS Pharma Limited is a global pharmaceutical company specializing in the manufacturing of a wide range of pharmaceutical products, including capsules, creams, injections, and various healthcare items. The company is recognized as the world's largest manufacturer of suppositories and pessaries, operating world-class facilities that prioritize quality and efficiency. Their mission focuses on discovering and rediscovering pharmaceutics to enhance well-being while increasing the accessibility of pharmaceuticals worldwide. The intended clients include healthcare providers and consumers seeking reliable and effective pharmaceutical solutions.
Company Leadership DS
VD
AM
SJ
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership CO
BL
BL
AS
Purdue Pharma is a developer and provider of prescription medicine. They were founded in 1892 and are currently headquartered in Stamford, Connecticut.
Company Leadership MK
MZ
KD
HG
Frequently Asked Questions Regarding Zydus Top Executives and Leadership Team
